| Product Code: ETC8870289 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Pharmacogenetic Testing Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Poland Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Poland Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Poland Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Poland Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Poland Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Poland Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Poland Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Poland Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Poland Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and adoption of personalized medicine in Poland |
4.2.2 Growing prevalence of chronic diseases requiring personalized treatment |
4.2.3 Supportive government regulations promoting pharmacogenetic testing |
4.3 Market Restraints |
4.3.1 High costs associated with pharmacogenetic testing |
4.3.2 Limited accessibility to advanced testing facilities in certain regions of Poland |
4.3.3 Lack of trained healthcare professionals for interpreting and implementing test results |
5 Poland Pharmacogenetic Testing Market Trends |
6 Poland Pharmacogenetic Testing Market, By Types |
6.1 Poland Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Poland Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Poland Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Poland Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Poland Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Poland Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Poland Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Poland Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Poland Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Poland Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Poland Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Poland Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Poland Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Poland Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Poland Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Poland Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Poland Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Poland Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Poland Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Poland Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Poland Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Poland Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Poland Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Poland Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Poland Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Poland Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Poland Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Poland Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Poland Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Poland Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Poland Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Poland Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Poland Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Poland Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Poland Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Poland Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Poland Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Poland Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Poland Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Poland Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Poland Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Poland Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Poland Pharmacogenetic Testing Market Export to Major Countries |
7.2 Poland Pharmacogenetic Testing Market Imports from Major Countries |
8 Poland Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Rate of adoption of pharmacogenetic testing by healthcare providers in Poland |
8.2 Number of partnerships between testing laboratories and healthcare facilities for increased accessibility |
8.3 Patient satisfaction scores related to personalized treatment outcomes |
9 Poland Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Poland Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Poland Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Poland Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Poland Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Poland Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Poland Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Poland Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Poland Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Poland Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Poland Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here